A model-based approach to the in vitro evaluation of anticancer activity

Cancer Chemotherapy and Pharmacology

Volumn 63, Issue 5, 2009, Pages 827-836

  Del Bene, Francesca ^a   Germani, Massimiliano ^a   De Nicolao, Giuseppe ^b   Magni, Paolo ^b   Re, Claudia Ernestina ^a   Ballinari, Dario ^a   Rocchetti, Maurizio ^a  

^a NERVIANO MEDICAL SCIENCES   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cellular responses to anticancer drugs; Model based approach; Pharmacodynamic analysis; Tumor growth inhibition model

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; PACLITAXEL; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG POTENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; STATISTICAL MODEL; TIME;

ADENOSINE TRIPHOSPHATE; ALGORITHMS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LETHAL DOSE 50; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS;

EID: 61449114851     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-008-0798-3     Document Type: Article

References (19)

1. DJ Adams 1989 In vitro pharmacodynamic assay for cancer drug development: application to cristanol, a new DNA intercalator Cancer Res 49 6615 6620
2. MR Boyd KD Paull 1995 Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen Drug Dev Res 34 91 109
3. TD Bradshaw MS Chua HL Browne V Trapani EA Sausville MFG Stevens 2002 In vitro evaluation of amino acid prodrugs of novel antitumour 2-(4-amino-3- methylphenyl)benzothiazoles Br J Cancer 86 8 1348 1354
4. P Carpinelli R Ceruti ML Giorgini P Cappella L Granellini V Croci A Degrassi G Tepido M Rocchetti P Vinello L Rusconi P Storici P Zugnoni C Arrigoni C Soncini C Alli V Patton A Marsiglio D Ballinari E Pesenti D Fancelli J Moll 2007 PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer Mol Cancer Ther 6 3158 3168
5. SP Crouch R Kozlowski KJ Slater J Fletcher 1993 The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity J Immunol Methods 160 81 88
6. C Csajka D Verotta 2006 Pharmacokinetic-pharmacodynamic modelling: history and perspectives J Pharmacokinet Pharmacodyn 33 227 279
7. F Fan KV Wood 2007 Bioluminescent assays for high-throughput screening Assay Drug Dev Technol 5 1 127 136
8. M Germani P Magni G De Nicolao I Poggesi A Marsiglio D Ballinari M Rocchetti 2003 In vitro cells growth pharmacodynamic studies: a new nonparametric approach to determine the relative importance of drug concentration and treatment time Cancer Chemoter Pharmacol 52 507 513
9. JE Kalns NJ Millenbaugh MG Wientjes JL-S Au 1995 Design and analysis of in vitro antitumor pharmacodynamic studies Cancer Res 55 5315 5322
10. K Keyes K Cox P Treadway L Mann C Shih MM Faul BA Teicher 2002 An in vitro tumor model: analysis of angiogenic factor expression after chemotherapy Cancer Res 62 5597 5602
11. MN Kirstein RC Brundage MM Moore BW Williams LA Hillman JW Dagit JE Fisher PH Marker RA Kratzke D Yee 2008 Pharmacodynamic characterization of gemcitabine cytotoxicity in an in vitro cell culture bioreactor system Cancer Chemother Pharmacol 61 291 299
12. LM Levasseur HK Slocum YM Rustum WR Greco 1998 Modeling of the time-dependency of in vitro drug cytotoxicity and resistance Cancer Res 58 5749 5761
13. W Li MS Lam A Birkeland A Riffel L Montana ME Sullivan JM Post 2006 Cell-based assays for profiling activity and safety properties of cancer drugs J Pharmacol Toxicol Methods 54 313 319
14. ED Lobo JP Balthasar 2002 Pharmacodynamic modeling of chemotherapeutic effects: application of a transit compartment model to characterize methotrexate effects in vitro AAPS PharmSci 4 42
15. DE Mager E Wyska WJ Jusko 2003 Diversity of mechanism-based pharmacodynamic models Drug Metab Dispos 31 510 518
16. P Magni M Simeoni I Poggesi M Rocchetti G De Nicolao 2006 A mathematical model to study the effects of drugs administration on tumor growth dynamics Math Biosci 200 127 151
17. NJ Millenbaugh NG Wientjes JL-S Au 2000 A pharmacodynamic analysis method to determine the relative importance of drug concentration and treatment time on effect Cancer Chemother Pharmacol 45 265 272
18. M Simeoni P Magni C Cammia G De Nicolao V Croci E Pesenti M Germani I Poggesi M Rocchetti 2004 Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents Cancer Res 64 1094 1101
19. RH Shoemaker 2006 The NCI60 human tumour cell line anticancer drug screen Nat Rev Cancer 6 813 823